On July, 27th 2023, twenty participants of a manager group from Ukraine with focus on “Healthcare” visited the Biotechnology Park in Luckenwalde. The aim was to get to know the health care system in Germany. The focus was on diagnostics as well as biotechnology solutions and they were explained in detail by the presentation of…
Please note, that the determination of TSHDS autoantibodies in the context of small fiber neuropathy diagnostics is not possible for an indefinite period of time due to supply difficulties of the starting material! Here you will find an overview of our current tests. For information about sample collection, shipping and billing, please click here!
CellTrend cooperates with Dr. Atheer Al-Nakkash, specialist for transfusion medicine at the “Deutsches Hämapherese Zentrum” in Cologne! The range of services offered there includes a variety of treatments. Among other things, Hemapheresis (removal of blood components outside the body) is used for chronic forms of autoimmune diseases such as Long Covid/PostCovid or ME/CFS. For more…
Please note that we only ship our ELISA kits until December, 12th this year! Please send your orders to mail@clltrend.de. Thank you very much!
We wish you a Merry Christmas and a Happy New Year 2023! Please note that our laboratory will be closed from December, 22nd 2022 until January, 1st 2023 due to the Christmas holidays. There will be no receiving of patient samples during this period! The last diagnostics of the patient samples will take place…
This week was special for us too. A camera team looked over our shoulders as we worked in the lab. Here is the post on the Long Covid Tests.
According to the congress report of the 14th annual meeting of the German Society of Nephrology, ten patients with severe ME/CFS underwent immunapheresis. In 7 out of 10 patients this leads to a significant improvement in symptoms. Prof. Dr. Scheibenbogen suspects an apheresis effect on the beta cell compartment, because autoantibodies against ß1 and ß2…
An article about CellTrend was published in the MAZ this week!
A new study about dysregulated autoantibodies in Post COVID Syndrome (PCS) has been published in Frontiers in Immunologie! Nearly 160 patients were included in the study and divided into four groups. Most PCS patients present a plethora of symptoms without clear evidence of organ dysfunction. The symptom severity of ME/CFS correlates with natural regulatory autoantibody…
The new CellTrend calendar for 2023 has just arrived. Exclusively we already give a small insight into the historical shares!
